CDRT15P11

Across TCGA pan-cancer cohorts, CDRT15P11 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CDRT15P11 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher CDRT15P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CDRT15P11 expression acts as an unfavorable survival marker.

DLBC, CHOL, and STAD are the cancer types where CDRT15P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	103	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	36	view →
UCS	DFS	Tertile	III,IV	0.116	0.441	.024	36	view →
THCA	OS	Tertile	All	0.275	0.947	.002	30	view →
PCPG	DFS	Tertile	All	0.519	0.833	.009	27	view →
BLCA	OS	Tertile	IV	0.052	0.575	<.001	18	view →
LAML	DFS	Tertile	All	0.174	0.590	.005	18	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	9	view →
OV	OS	Tertile	II,III,IV	0.759	0.845	.043	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

CDRT15P11–DLBC (DFS)

Open the DLBC breakdown →